Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel B Jones

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Clinical Kidney Journal|April 11, 2015
Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune diseaseRachel B Jones, Michael Walsh, Afzal N Chaudhry, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 10, 2022
Avacopan for ANCA-associated vasculitis - information for prescribersDominic McGovern, Rachel B Jones, Lisa C Willcocks, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 22, 2019
Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated VasculitisMark E McClure, James Wason, Seerapani Gopaluni, et al.
Journal of Autoimmunity|January 15, 2015
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case seriesDarren M Roberts, Rachel B Jones, Rona M Smith, et al.
Journal of Autoimmunity|January 6, 2015
Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune diseaseDarren M Roberts, Rachel B Jones, Rona M Smith, et al.
The Journal of Rheumatology|August 3, 2017
Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA SubtypeAladdin J Mohammad, Kristian H Mortensen, Judith Babar, et al.
Arthritis and Rheumatism|June 26, 2012
Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitisRona M Smith, Rachel B Jones, Mary-Jane Guerry, et al.
Trials|March 9, 2017
Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trialSeerapani Gopaluni, Rona M Smith, Michelle Lewin, et al.
Nature Reviews. Rheumatology|June 5, 2025
Advances in the treatment of ANCA-associated vasculitisGiorgio Trivioli, Marta Casal Moura, Andreas Kronbichler, et al.
Rheumatology (Oxford, England)|December 6, 2014
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitisFederico Alberici, Rona M Smith, Rachel B Jones, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Clinical Kidney Journal|April 11, 2015
Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune diseaseRachel B Jones, Michael Walsh, Afzal N Chaudhry, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 10, 2022
Avacopan for ANCA-associated vasculitis - information for prescribersDominic McGovern, Rachel B Jones, Lisa C Willcocks, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 22, 2019
Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated VasculitisMark E McClure, James Wason, Seerapani Gopaluni, et al.
Journal of Autoimmunity|January 15, 2015
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case seriesDarren M Roberts, Rachel B Jones, Rona M Smith, et al.
Journal of Autoimmunity|January 6, 2015
Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune diseaseDarren M Roberts, Rachel B Jones, Rona M Smith, et al.
The Journal of Rheumatology|August 3, 2017
Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated Vasculitis: The Influence of ANCA SubtypeAladdin J Mohammad, Kristian H Mortensen, Judith Babar, et al.
Arthritis and Rheumatism|June 26, 2012
Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitisRona M Smith, Rachel B Jones, Mary-Jane Guerry, et al.
Trials|March 9, 2017
Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trialSeerapani Gopaluni, Rona M Smith, Michelle Lewin, et al.
Nature Reviews. Rheumatology|June 5, 2025
Advances in the treatment of ANCA-associated vasculitisGiorgio Trivioli, Marta Casal Moura, Andreas Kronbichler, et al.
Rheumatology (Oxford, England)|December 6, 2014
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitisFederico Alberici, Rona M Smith, Rachel B Jones, et al.
Pageof 6